Clinical Significance of NDRG1 Expression in Non-Small Cell Lung Cancer Tissues

FAN Chui-feng,LIN Xu-yong,LIU Nan,LIU Di,XIE Cheng-yao,WANG En-hua

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2011.03.013

2011-01-01

Abstract:OBJECTIVE: To investigate the expression and clinical significance of NDRG1 in non-small cell lung cancer(NSCLC) tissues.METHODS: The protein and mRNA expression of NDRG1 in NSCLC tissues were examined using immunohistochemistry(IHC) and RT-PCR respectively.RESULTS: NDRG1 expression was found in cytoplasm(46/85,54.1%),nuclear(18/85,21.2%) and cell membrane(9/85,10.6%) in primary lung cancer tissues with a total positive rate of 61.2%(52/85) which was higher than that in normal lung tissues(22/85,25.9%,P=0.000).NDRG1 expression in paired lymph node metastases(17/40,42.5%) was lower than that in primary NSCLC(P=0.003) but higher than that in normal lung tissues(P=0.002).Higher NDRG1 expression was found in NSCLC with large tumor size(≥3 cm)(45/59,76.3% vs 7/26,26.9%,P=0.000).In addition,NDRG1 mRNA level in primary NSCLC tissues was higher than that in normal lung tissues(P=0.000).Level of NDRG1 mRNA was correlated with the expression level of NDRG1 protein in primary NSCLC(P=0.025).Furthermore,the mean survival time of patients with NDRG1-positive tumors((35.84±15.07) months) was significantly shorter than that of patients with NDRG1-negative tumors((63.69±12.16) months,P=0.002).CONCLUSION: The present findings indicate an upregulation of NDRG1 expression during tumor progress which may have prognostic significance for patients with NSCLC.